You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain
|
|---|---|
| Published in |
Orphanet Journal of Rare Diseases, March 2013
|
| DOI | 10.1186/1750-1172-8-47 |
| Pubmed ID | |
| Authors |
Saskia M Rombach, Bouwien E Smid, Machtelt G Bouwman, Gabor E Linthorst, Marcel G W Dijkgraaf, Carla E M Hollak |
| Abstract |
Fabry disease is an X-linked lysosomal storage disorder caused by α-galactosidase A deficiency leading to renal, cardiac, cerebrovascular disease and premature death. Treatment with α-galactosidase A (enzyme replacement therapy, ERT) stabilises disease in some patients, but long term effectiveness is unclear. |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 14% |
| Netherlands | 1 | 14% |
| United Kingdom | 1 | 14% |
| Unknown | 4 | 57% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 71% |
| Scientists | 2 | 29% |
Mendeley readers
The data shown below were compiled from readership statistics for 150 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 148 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 20 | 13% |
| Researcher | 19 | 13% |
| Student > Master | 19 | 13% |
| Student > Bachelor | 19 | 13% |
| Other | 12 | 8% |
| Other | 23 | 15% |
| Unknown | 38 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 48 | 32% |
| Agricultural and Biological Sciences | 16 | 11% |
| Biochemistry, Genetics and Molecular Biology | 13 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 5% |
| Neuroscience | 6 | 4% |
| Other | 19 | 13% |
| Unknown | 40 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 July 2023.
All research outputs
#1,295,652
of 24,169,085 outputs
Outputs from Orphanet Journal of Rare Diseases
#132
of 2,841 outputs
Outputs of similar age
#9,972
of 200,465 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#2
of 37 outputs
Altmetric has tracked 24,169,085 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,841 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.9. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 200,465 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.